SANN.SW
Price:
$9.36
Market Cap:
$113.31M
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes vamorolone, which is being developed as treatments for Duchenne muscular dystrophy (DMD). Its clinical stage pipeline also comprises lonodelestat (POL6014) to treat cystic fibrosis and other neutrophilic pulmonary diseases, as well as omigapil that treats congenital muscular dystrophies. The company also out-licenses outside North America and France rights to its approved product, Raxone (...[Read more]
Industry
Biotechnology
IPO Date
2006-11-03
Stock Exchange
SIX
Ticker
SANN.SW
According to Santhera Pharmaceuticals Holding AG’s latest financial reports and current stock price. The company's current Enterprise Value is 108.00M. This represents a change of 0.38% compared to the average of 107.60M of the last 4 quarters.
The mean historical Enterprise Value of Santhera Pharmaceuticals Holding AG over the last ten years is 192.68M. The current 108.00M Enterprise Value has changed 5.51% with respect to the historical average. Over the past ten years (40 quarters), SANN.SW's Enterprise Value was at its highest in in the September 2018 quarter at 1.05B. The Enterprise Value was at its lowest in in the September 2017 quarter at 0.
Average
192.68M
Median
140.22M
Minimum
67.21M
Maximum
402.42M
Discovering the peaks and valleys of Santhera Pharmaceuticals Holding AG Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.27%
Maximum Annual Enterprise Value = 402.42M
Minimum Annual Increase = -66.50%
Minimum Annual Enterprise Value = 67.21M
Year | Enterprise Value | Change |
---|---|---|
2023 | 104.17M | -18.08% |
2022 | 127.16M | 89.19% |
2021 | 67.21M | -30.01% |
2020 | 96.04M | -37.34% |
2019 | 153.28M | 96.13% |
2018 | 78.15M | -66.50% |
2017 | 233.32M | -17.38% |
2016 | 282.40M | -29.82% |
2015 | 402.42M | 5.17% |
2014 | 382.64M | 4.27% |
The current Enterprise Value of Santhera Pharmaceuticals Holding AG (SANN.SW) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
99.52M
5-year avg
109.57M
10-year avg
192.68M
Santhera Pharmaceuticals Holding AG’s Enterprise Value is less than Basilea Pharmaceutica AG (598.13M), less than Idorsia Ltd (1.30B), less than Newron Pharmaceuticals S.p.A. (206.05M), greater than Evolva Holding SA (725.52K), greater than Molecular Partners AG (-19981600.00),
Company | Enterprise Value | Market cap |
---|---|---|
598.13M | $555.15M | |
1.30B | $274.62M | |
206.05M | $155.13M | |
725.52K | $6.56M | |
-19981600.00 | $136.10M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Santhera Pharmaceuticals Holding AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Santhera Pharmaceuticals Holding AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Santhera Pharmaceuticals Holding AG's Enterprise Value?
What is the highest Enterprise Value for Santhera Pharmaceuticals Holding AG (SANN.SW)?
What is the 3-year average Enterprise Value for Santhera Pharmaceuticals Holding AG (SANN.SW)?
What is the 5-year average Enterprise Value for Santhera Pharmaceuticals Holding AG (SANN.SW)?
How does the current Enterprise Value for Santhera Pharmaceuticals Holding AG (SANN.SW) compare to its historical average?